BioCentury | Apr 2, 2009
Distillery Therapeutics

Indication: Various

...in JNK3-deficient mice and testing JNK3 inhibitors for their antiangiogenic effects. An SDF-1 antibody from RegenMed Corp....
BioCentury | Feb 20, 2006
Clinical News

RegenMed preclinical data

...retinal architecture leading to vision problems. Data were presented at the Angiogenesis meeting in Miami. RegenMed Corp....
Items per page:
1 - 2 of 2
BioCentury | Apr 2, 2009
Distillery Therapeutics

Indication: Various

...in JNK3-deficient mice and testing JNK3 inhibitors for their antiangiogenic effects. An SDF-1 antibody from RegenMed Corp....
BioCentury | Feb 20, 2006
Clinical News

RegenMed preclinical data

...retinal architecture leading to vision problems. Data were presented at the Angiogenesis meeting in Miami. RegenMed Corp....
Items per page:
1 - 2 of 2